NY-AQARA
23.11.2021 09:02:36 CET | Business Wire | Press release
Aqara, a leading provider of smart home products, announced today the launch of its next-gen flagship home security camera, the Camera Hub G3. The new camera is a 2K, pan-and-tilt camera with the local facial and gesture recognition features, and it integrates a built-in Zigbee 3.0 hub, allowing the device to connect up to 128 Aqara accessories*. It is now available on the Aqara Amazon brand stores in the US , Canada and France , and is also expected to be sold by authorized Aqara retailers in North America, Europe and Asia in the following weeks**.
Thanks to a powerful NPU-equipped processor, the Aqara Camera Hub G3 supports facial recognition and gesture recognition features, both of which can be used to trigger home automations. Users can configure to receive push notifications when their young kids arrive home or when a stranger is detected (i.e. a familiar face was not detected), or to stop video recording when the face of a family member or a preset hand gesture is recognized. The AI-enabled features will make homes safer, and make people’s lives even easier as users can now trigger home automation with certain hand gestures or simply a recognized face.
The G3 camera hub also supports automatic cruising, face tracking as well as pet tracking, all enabled by the 110° wide-angle lens and the pan-and-tilt motor which provides up to 340° rotation angle. The pan-and-tilt motor can be controlled manually, by the preset cruising path, or via home automations (for example, to turn to the front door when Door & Window Sensor is triggered). Combined with the high-resolution 2304×1296 pixel sensor and the infrared night vision enabled by the 940 nm LEDs, which are invisible at night, the G3 protects homes in 360-degree with no blind spot, day and night.
Compared to the previous G2H Camera Hub, the new G3 provides other advanced features including:
- Wider compatibility with third-party platforms : as a camera it supports not only HomeKit Secure Video*** but also streaming to Amazon Alexa and Google Assistant smart displays, while as a hub it allows connected child devices to support a wide range of third-party ecosystems and voice assistants, such as HomeKit, Alexa, Google Home, IFTTT, and more;
- Local infrared control : the built-in IR controller allows the G3 to automate the infrared-compatible devices, and the IR automation is local which means it remains functioning without the Internet connection;
- Dual-band Wi-Fi support : both 2.4GHz and 5GHz Wi-Fi networks are supported;
- Privacy protection : it is equipped with a privacy shutter that physically covers the camera lens, and the shutter can be activated manually and automatically;
- Type-C port with video out : it uses the modern and universal connector that supports low-latency, high-definition video output via UVC protocol.
To celebrate the launch, Aqara is now offering limited-time discounts for the new Camera Hub G3 on its Amazon brand stores. North American customers will enjoy a 20% discount at check with the promo code USG3PRGE in the US and Canada , and the code will be valid through Nov 24, 2021. Aqara also offers French customers a 20€ OFF discount at its Amazon.fr store , with the promo code CAMERAG3FR, and the offering will expire on Nov 25, 2021.
For more details of the G3 camera hub, please visit our website .
* To connect up to 128 devices, Zigbee routers/repeaters such as Smart Wall Switch (With Neutral) and Smart Plug are required.
** Product availability may vary among different retail channels, and could be updated all the time. It’s recommended to check with the regional retailer(s) for real time availability.
*** In HomeKit Secure Video mode, the camera records in Full HD 1080p and Pan/Tilt controls are not available due to the current limitations of HomeKit technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211123005627/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 10:00:00 CEST | Press release
Gabriele Salvatores, together with Rob Minkoff, Catherine Hardwicke, Jed Weintrob, Christina Lee Storm, Nils Hartmann, Guillem Martinez Roura, Filippo Rizzante, Giacomo Mineo, Brian Welk and Denise Negri, will judge the short films in competition based on creativity, production quality and the use of Artificial Intelligence. Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, wh
Bregal Milestone Announces Majority Growth Investment in CoreGo, a Leading European Open-Loop Payment and Event Technology Company29.4.2026 10:00:00 CEST | Press release
Investment follows over 98% annual growth and supports CoreGo’s continued market expansion Bregal Milestone, a leading European software growth private equity firm, today announced a majority strategic growth investment in CoreGo Oy ("CoreGo" or the "Company"), a leading provider of open-loop payments and integrated technology solutions for festivals, sports events, and venues across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427991105/en/ Founded in Helsinki in 2015 by Hannu Elomaa and CTO Nikoteemu Väänänen, CoreGo has built one of Europe's most differentiated open-loop payment infrastructure and event technology businesses. Serving approximately 250 customers across the Nordics and DACH region, the Company delivers an integrated showtime-critical suite of solutions through CoreGo Cloud, unifying payments, access, networks, and data into a single real-time operating system. CoreGo’s in-house private network
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
